Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Dean Hanisch Insider Profile
4 Followers
Dean Hanisch, Senior Officer at Tetra Bio-Pharma, holds 383.75K shares in Stria Lithium (Ticker: TSE:SRA), holds 617.00K shares in Tetra Bio-Pharma (Ticker: TSE:TBP). Most recently, Dean Hanisch Bought ― shares of Stria Lithium on Nov 29, 2023 for an estimated value of 2.94K.
Profitable Transactions
0 out of 5 Profitable Transactions
Average Return
-53.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Dean Hanisch holds in companies
Most Profitable Insider Trade
The most profitable trade made by Dean Hanisch
Dean Hanisch's Trading History
Tetra Bio-Pharma
May 01, 2012
Senior Officer
Informative Buy
66.95K
C$12.34K
Stria Lithium
Nov 29, 2023
Chief Executive Officer
Informative Buy
2.94K
C$30.70K
List of latest transactions for each holding click on a transaction to see Dean Hanisch's performance on stock
You May Also Like
Dean Hanisch insider profile FAQ
What is the percentage of profitable transactions made by Dean Hanisch?
The percentage of profitable transactions made by Dean Hanisch is 0%.
What is the average return per transaction made by Dean Hanisch?
The average return per transaction made by Dean Hanisch is -53.00%.
What stocks does Dean Hanisch hold?
Dean Hanisch holds: TSE:TBP, TSE:SRA stocks.
What was Dean Hanisch’s latest transaction?
Dean Hanisch latest transaction was an Informative Buy of C$2.94K.
What was Dean Hanisch's most profitable transaction?
Dean Hanisch’s most profitable transaction was an Informative Buy of TSE:SRA stock on November 29, 2023. The return on the trade was -42.80%.
What is Dean Hanisch's role in Tetra Bio-Pharma?
Dean Hanisch's role in Tetra Bio-Pharma is Senior Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.